ALGN
Price
$136.86
Change
-$2.26 (-1.62%)
Updated
Sep 8 closing price
Capitalization
9.92B
50 days until earnings call
NVST
Price
$21.15
Change
-$0.16 (-0.75%)
Updated
Sep 8 closing price
Capitalization
3.51B
50 days until earnings call
Interact to see
Advertisement

ALGN vs NVST

Header iconALGN vs NVST Comparison
Open Charts ALGN vs NVSTBanner chart's image
Align Technology
Price$136.86
Change-$2.26 (-1.62%)
Volume$1.42M
Capitalization9.92B
Envista Holdings
Price$21.15
Change-$0.16 (-0.75%)
Volume$1.43M
Capitalization3.51B
ALGN vs NVST Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. NVST commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and NVST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (ALGN: $136.86 vs. NVST: $21.15)
Brand notoriety: ALGN: Notable vs. NVST: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 81% vs. NVST: 67%
Market capitalization -- ALGN: $9.92B vs. NVST: $3.51B
ALGN [@Pharmaceuticals: Other] is valued at $9.92B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.51B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, NVST is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 3 bearish.
  • NVST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than NVST.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -3.59% price change this week, while NVST (@Pharmaceuticals: Other) price change was -0.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.88%. For the same industry, the average monthly price growth was +4.94%, and the average quarterly price growth was +24.93%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.88% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($9.92B) has a higher market cap than NVST($3.52B). NVST has higher P/E ratio than ALGN: NVST (66.59) vs ALGN (23.12). NVST YTD gains are higher at: 9.642 vs. ALGN (-34.363). ALGN has higher annual earnings (EBITDA): 793M vs. NVST (303M). NVST has more cash in the bank: 1.11B vs. ALGN (901M). ALGN has less debt than NVST: ALGN (123M) vs NVST (1.6B). ALGN has higher revenues than NVST: ALGN (3.97B) vs NVST (2.55B).
ALGNNVSTALGN / NVST
Capitalization9.92B3.52B282%
EBITDA793M303M262%
Gain YTD-34.3639.642-356%
P/E Ratio23.1266.5935%
Revenue3.97B2.55B155%
Total Cash901M1.11B81%
Total Debt123M1.6B8%
FUNDAMENTALS RATINGS
ALGN vs NVST: Fundamental Ratings
ALGN
NVST
OUTLOOK RATING
1..100
5878
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6691
PRICE GROWTH RATING
1..100
6446
P/E GROWTH RATING
1..100
9048
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (73) in the null industry is in the same range as ALGN (74) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ALGN’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as ALGN (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as NVST (91) in the null industry. This means that ALGN’s stock grew similarly to NVST’s over the last 12 months.

NVST's Price Growth Rating (46) in the null industry is in the same range as ALGN (64) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ALGN’s over the last 12 months.

NVST's P/E Growth Rating (48) in the null industry is somewhat better than the same rating for ALGN (90) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNNVST
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
Bearish Trend 7 days ago
72%
Bearish Trend 7 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGCCX100.53N/A
N/A
Gabelli Growth C
VTSNX154.01N/A
N/A
Vanguard Total Intl Stock Index I
HFMVX37.00N/A
N/A
Hartford MidCap R6
LSGGX24.74N/A
N/A
Loomis Sayles Global Growth Y
MNHWX27.31N/A
N/A
Manning & Napier Pro-Blend Max Term W

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been closely correlated with BAX. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-1.62%
BAX - ALGN
71%
Closely correlated
-1.35%
NVST - ALGN
54%
Loosely correlated
-0.75%
LUNG - ALGN
52%
Loosely correlated
-2.30%
SAUHY - ALGN
49%
Loosely correlated
+1.59%
ILMN - ALGN
48%
Loosely correlated
-0.76%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with BIO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.75%
BIO - NVST
57%
Loosely correlated
-1.71%
A - NVST
55%
Loosely correlated
-0.48%
ALGN - NVST
54%
Loosely correlated
-1.62%
XRAY - NVST
53%
Loosely correlated
-2.80%
MTD - NVST
52%
Loosely correlated
+0.68%
More